170 related articles for article (PubMed ID: 29479987)
21. Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice.
Gani SA; Muhammad SA; Kura AU; Barahuie F; Hussein MZ; Fakurazi S
PLoS One; 2019; 14(5):e0217009. PubMed ID: 31141523
[TBL] [Abstract][Full Text] [Related]
22. Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma.
Yao M; Yao DF; Bian YZ; Zhang CG; Qiu LW; Wu W; Sai WL; Yang JL; Zhang HJ
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):289-94. PubMed ID: 21669573
[TBL] [Abstract][Full Text] [Related]
23. Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats.
Ghosh A; Ghosh D; Sarkar S; Mandal AK; Thakur Choudhury S; Das N
Eur J Cancer Prev; 2012 Jan; 21(1):32-41. PubMed ID: 21968689
[TBL] [Abstract][Full Text] [Related]
24. Chronic Administration of Diethylnitrosamine and 2-Acetylaminofluorene Induces Hepatocellular Carcinoma in Wistar Rats.
Sánchez-Meza J; Campos-Valdez M; Domínguez-Rosales JA; Godínez-Rubí JM; Rodríguez-Reyes SC; Martínez-López E; Zúñiga-González GM; Sánchez-Orozco LV
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176094
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-26a systemic administration attenuates tumor formation in hepatocellular carcinoma mouse model.
Badr AM; El-Ahwany E; Goda L; Nagy F; Helal N; El Deeb S
Pak J Pharm Sci; 2021 May; 34(3):925-932. PubMed ID: 34602415
[TBL] [Abstract][Full Text] [Related]
26. Improving Anti-Cancer Potentiality and Bioavailability of Gallic Acid by Designing Polymeric Nanocomposite Formulation.
Ahmed HH; Galal AF; Shalby AB; Abd-Rabou AA; Mehaya FM
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3137-3146. PubMed ID: 30486601
[TBL] [Abstract][Full Text] [Related]
27. Melatonin modulates the oxidant-antioxidant imbalance during N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
Dakshayani KB; Subramanian P; Manivasagam T; Essa MM; Manoharan S
J Pharm Pharm Sci; 2005 Aug; 8(2):316-21. PubMed ID: 16124941
[TBL] [Abstract][Full Text] [Related]
28. Protective Effects of Total Glucosides of Paeony on N-nitrosodiethylamine-induced Hepatocellular Carcinoma in Rats via Down-regulation of Regulatory B Cells.
Song SS; Yuan PF; Li PP; Wu HX; Ni WJ; Lu JT; Wei W
Immunol Invest; 2015; 44(6):521-35. PubMed ID: 26207789
[TBL] [Abstract][Full Text] [Related]
29. The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib.
Elsadek B; Mansour A; Saleem T; Warnecke A; Kratz F
Dig Liver Dis; 2017 Feb; 49(2):213-222. PubMed ID: 27825923
[TBL] [Abstract][Full Text] [Related]
30. Metabolome Analyses Uncovered a Novel Inhibitory Effect of Acyclic Retinoid on Aberrant Lipogenesis in a Mouse Diethylnitrosamine-Induced Hepatic Tumorigenesis Model.
Qin XY; Tatsukawa H; Hitomi K; Shirakami Y; Ishibashi N; Shimizu M; Moriwaki H; Kojima S
Cancer Prev Res (Phila); 2016 Mar; 9(3):205-14. PubMed ID: 26744170
[TBL] [Abstract][Full Text] [Related]
31. Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
Ramakrishnan G; Augustine TA; Jagan S; Vinodhkumar R; Devaki T
Exp Oncol; 2007 Mar; 29(1):39-44. PubMed ID: 17431387
[TBL] [Abstract][Full Text] [Related]
32. Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats.
Sivalokanathan S; Ilayaraja M; Balasubramanian MP
Mol Cell Biochem; 2006 Jan; 281(1-2):87-93. PubMed ID: 16328960
[TBL] [Abstract][Full Text] [Related]
33. In vivo modulation of iNOS pathway in hepatocellular carcinoma by Nigella sativa.
Fathy M; Nikaido T
Environ Health Prev Med; 2013 Sep; 18(5):377-85. PubMed ID: 23609474
[TBL] [Abstract][Full Text] [Related]
34. 5H-benzo[h]thiazolo[2,3-b]quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reduction.
Keshari AK; Singh AK; Kumar U; Raj V; Rai A; Kumar P; Kumar D; Maity B; Nath S; Prakash A; Saha S
Drug Des Devel Ther; 2017; 11():2981-2995. PubMed ID: 29075102
[TBL] [Abstract][Full Text] [Related]
35. 24-hour rhythms in oxidative stress during hepatocarcinogenesis in rats: effect of melatonin or alpha-ketoglutarate.
Subramanian P; Dakshayani KB; Pandi-Perumal SR; Trakht I; Cardinali DP
Redox Rep; 2008; 13(2):78-86. PubMed ID: 18339250
[TBL] [Abstract][Full Text] [Related]
36. Cytokines as important playmakers of experimental hepatocarcinogenesis confounded by diabetes.
Abdel-Hamid NM; Nazmy MH; Abdel-Ghany MI; Nazmy WH
Ann Hepatol; 2012; 11(1):118-27. PubMed ID: 22166570
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the antitumor activity of platinum nanoparticles in the treatment of hepatocellular carcinoma induced in rats.
Medhat A; Mansour S; El-Sonbaty S; Kandil E; Mahmoud M
Tumour Biol; 2017 Jul; 39(7):1010428317717259. PubMed ID: 28720064
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
Zaghloul RA; El-Shishtawy MM; El Galil KH; Ebrahim MA; Metwaly AA; Al-Gayyar MM
Eur J Pharmacol; 2015 Jan; 746():353-62. PubMed ID: 25449037
[TBL] [Abstract][Full Text] [Related]
39. [Expression of glypican-3, hepatocyte antigen, alpha-fetoprotein, CD34 and CD10 in hepatocellular carcinoma: a clinicopathologic analysis of 375 cases].
Du JL; Wang YL; Shi HY; Guo AT; Wei LX
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):309-13. PubMed ID: 22883669
[TBL] [Abstract][Full Text] [Related]
40. Myricetin Selectively Induces Apoptosis on Cancerous Hepatocytes by Directly Targeting Their Mitochondria.
Seydi E; Rasekh HR; Salimi A; Mohsenifar Z; Pourahmad J
Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):249-58. PubMed ID: 26919160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
